Abstract
This workshop attempted to summarize the epidemiologic evidence bearing on the proposed benefits and suspected risks of oestrogen therapy. We illustrated the sorts of data available, discussed their limitations and attempted to quantify their effects. The ultimate goal of this exercise was to permit some idea of the balance between risks and benefits of oestrogen therapy. From the outset, we concede that no simple equation can be derived to demonstrate a positive or negative balance sheet for oestrogen therapy. This is true because of gaps in our knowledge about the full effects of exogenous oestrogens, vagueness in the measures we use to value the risks and benefits, and widely different standards of practice which could affect risks and benefits.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albrecht, B. H., Schiff, I., Tulchinsky, D. and Ryan, K. J. (1981). Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes. Am. J. Obstet. Gynecol., 139, 631
Antunes, C. M. F., Stolley, P. D., Rosenshein, N. B., Davies, J. L., Tonascia, J. A., Brown, C., Burnett, L., Rutledge, A., Pokempner, M. and Garcia, R. (1979). Endometrial cancer and estrogen use. Reports of a large case—control study. N. Engl. J. Med., 300, 9
Boston Collaborative Drug Surveillance Program, Boston University Medical Center (1974). Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to post-menopausal estrogen therapy. N. Engl. J. Med., 290, 15
Bradley, D. D., Wingerd, J., Petitti, D. B., Krauss, R. M. and Ramcharan, S. (1978). Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N. Engl. J. Med., 288, 17
Burch, J. C., Byrd, B. F. and Vaughn, W. K. (1975). The effects of long-term estrogen administration to women following hysterectomy. In van Keep, P. A. and Lauritzen, C. (eds.). Estrogens in the Post-Menopause. Frontiers in Hormone Research. vol. 3, pp. 208–14. ( Basel: Karger )
Campbell, S. (1976). Double blind psychometric studies on the effects of natural estrogens on post-menopausal women. In Campbell, S. (ed.). The Management of the Menopause and Post-menopausal Years, pp. 149–58. ( Baltimore: University Park Press )
Casagrande, J., Gerkins, V., Henderson, B. E., Mach, T. and Pike, M. C. (1976). Brief communications: exogenous estrogens and breast cancer in women with natural menopause. J. Natl. Cancer Inst., 56, 839
Coope, J. (1976). Double blind cross-over study of estrogen replacement therapy. In Campbell, S. (ed.). The Management of the Menopause and Post-menopausal Years, pp. 159–68. ( Baltimore: University Park Press )
Coronary Drug Project Research Group (1970). The Coronary Drug Project. Initial findings leading to modifications of its research protocol. J. Am. Med. Assoc.; 214, 1303
Cramer, D. (1980). Epidemiology of endometrial cancer. In Koss, L. G. (ed.). Recent advances in endometrial neoplasia. Acta Cytol., 24, 478
Cramer, D. W., Devesa, S. S. and Welch, W. R. (1981). Trends in the incidence of endometrioid and clear cell cancer of the ovary in the United States. Am. J. Epidemiol., 114, 201
Cramer, D. W. and Knapp, R. C. (1979). Review of epidemiologic studies of endometrial cancer and exogenous estrogen. Obstet. Gynecol., 54, 521
Furman, R. H. (1971). Coronary heart disease and the menopause. In Ryan, K. J. and Gibson, D. C. (eds.). Publication no. 73–319, p. 39. United States Department of Health, Education and Welfare
Gallagher, J. C. and Nordin, B. E. C. (1974). Calcium metabolism and the menopause. In Curry, A. S. and Hewitt, J. V. (eds.). Biochemistry of Women: Clinical Concepts, pp 145–75. ( Cleveland: CRC )
Gambrell, R. D. (1979). The role of hormones in the etiology of breast and endometrial cancer. Acta Obstet. Gynecol. Scand. Suppl., 88, 73
Gray, L. A., Christopherson, W. M. and Hoover, R. N. (1977). Estrogens and endometrial carcinoma. Obstet. Gynecol., 49, 385
Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T. and Parker, R. T. (1979). Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am. J. Obstet. Gynecol., 133, 525
Hoover, R., Gray, L. A., Cole, P. and MacMahon, B. (1976). Menopausal estrogens and breast cancer. N. Engl. J. Med., 295, 401
Hulka, B. S., Hogue, C. J. R. and Greenberg, B. G. (1978). Methodologic issues in epidemiologic studies of endometrial cancer and exogenous estrogen. Am. J. Epidemiol., 107, 267
Hutchinson, T. A., Polansky, S. M. and Feinstein, A. R. (1979). Post-menopausal oestrogens protect against fractures of hip and distal radius. Lancet, 2, 705
Jick, H., Walker, A. M., Watkins, R. N., D’Ewart, D. C., Hunter, J. R., Danford, A., Madsen, S., Dinan, B. J. and Rothman, K. J. (1980). Replacement estrogens and breast cancer. Am. J. Epidemiol., 112, 586
Jick, H., Watkins, R. N., Hunter, J. R., Dinan, B.J., Madsen, S., Rothman, K.J. and Walker, A. M. (1979). Replacement estrogens and endometrial cancer. N. Engl. J. Med., 300, 218
Lindsay, R., Aitken, J. M., Anderson, J. B., Hart, D. M., MacDonald, E. B. and Clarke, A. C. (1976). Long-term prevention of post-menopausal osteoporosis by oestrogen. Lancet, 1, 1038
McDonald, T. W., Annegers, J. F., O’Fallon, W. M., Dockerty, M. B., Malkasian, G. D. and Kurland, L. T. (1977). Exogenous estrogen and endometrial carcinoma: case—control and incidence study. Am. J. Obstet. Gynecol., 127, 572
Mack, T. M., Pike, M. C., Henderson, B. E., Pfeffer, R. I., Gerkins, V. R., Arthur, M. and Brown, S. E. (1976). Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med., 294, 1262
Mustacchi, P. and Gordan, G. S. (1958). Frequency of cancer in estrogen-treated osteoporotic women. In Segaloff, A. (ed.). Breast Cancer. The Second Biennial Louisiana Cancer Conference, pp. 163–9. ( St. Louis: Mosby )
Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D. and Beckman, E. M. (1979). Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet. Gynecol., 53, 277
Nordin, B. E. C. (1971). Clinical significance and pathogenesis of osteoporosis. Br. Med. J., 1, 571
Pfeffer, R. I., Whipple, G. H., Kurosaki, T. T. and Chapman, J. M. (1978). Coronary risk and estrogen use in post-menopausal woman. Am. J. Epidemiol., 107, 479
Rosenberg, L., Armstrong, B., Phil, D. and Jick, H. (1976). Myocardial infarction and estrogen therapy in post-menopausal women. N. Engl. J. Med., 294, 1256
Ross, R. K., Paganini-Hill, A., Gerkins, V. R., Mack, T. M., Pfeffer, R., Arthur, M. and Henderson, B. E. (1980). A case—control study of menopausal estrogen therapy and breast cancer. J. Am. Med. Assoc., 243, 1635
Ross, R. K., Paganini-Hill, A., Mack, T. M., Arthur, M. and Henderson B. E. (1981). Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet, 1, 858
Ryan, K. J. (1976). Estrogen and atherosclerosis. Clin. Obstet. Gynecol., 19, 805
Sartwell, P. E., Arthes, F. G. and Tonascia, J. A. (1977). Exogenous hormones, reproductive history and breast cancer. J. Natl. Cancer Inst., 59, 1589
Schiff, I., Regestein, Q., Tulchinsky, D. and Ryan, K.J. (1979). Effects of estrogens on sleep and psychological state of the hypogonadal woman. J. Am. Med. Assoc., 242, 2405
Schiff, I., Tulchinsky, D., Cramer, D. and Ryan, K. J. (1980a). Oral medroxypro- gesterone treatment of post-menopausal symptoms. J. Am. Med. Assoc., 244, 1443
Schiff, I. Tulchinsky, D. and Ryan, K. J. (1977). Vaginal absorption of estrone and estradiol-170. Fertil. Steril.,131, 585
Schiff, I., Tulchinsky, D., Ryan, K. J., Kadner, S. and Levitz, M. (1980b). Plasma estriol and its conjugates following administration of estriol to post-menopausal women: correlations with gonadotropin levels. Am. J. Obstet. Gynecol., 138, 1137
Shapiro, S., Kaufman, D. W., Slone, D., Rosenberg, L., Miettinen, O. S., Stolley, P. D., Rosenshein, N. B., Watring, W. G., Leavitt, T. and Knapp, R. C. (1980). Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. N. Engl. J. Med., 303, 485
Silverberg, S. G., Mullen, D., Faraci, J. A., Makowski, E. L., Miller, A., Finch, J. L. and Sutherland, J. V. (1980). Endometrial carcinoma: clinical—pathological comparison of cases in post-menopausal women receiving and not receiving exogenous estrogens. Cancer, 45, 3018
Smith, D. C., Prentice, R., Thompson, D. J. and Herrmann, W. L. (1975). Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med., 293, 1164
Thom, M. H., White, P. J., Sturdee, D. W., Paterson, M. E. L. and Studd, J. W. W. (1979). Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet, 2, 455
Wallach, S. and Henneman, P. H. (1959). Prolonged estrogen therapy in post-menopausal women. J. Am. Med. Assoc., 171, 1637
Weinstein, M. C. (1980). Estrogen use in post-menopausal women — Costs, risks and benefits. N. Engl. J. Med., 303, 308
Weiss, N. S. and Sayvetz, T. A. (1980). Incidence of endometrial cancer in relation to use of oral contraceptives. N. Engl. J. Med., 302, 551
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R. and Daling, J. R. (1980). Decreased risk of fractures of the hip and lower forearm with post-menopausal use of estrogen. N. Engl. J. Med., 303, 1195
Whitehead, M. I. (1978). The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas, 1, 87
Ziel, H. K. and Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med., 293, 1167
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 MTP Press Limited
About this chapter
Cite this chapter
van Keep, P.A., Utian, W.H., Vermeulen, A. (1982). Epidemiologic aspects of the benefits and risks of oestrogen therapy. In: van Keep, P.A., Utian, W.H., Vermeulen, A. (eds) The Controversial Climacteric. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7253-0_14
Download citation
DOI: https://doi.org/10.1007/978-94-011-7253-0_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7255-4
Online ISBN: 978-94-011-7253-0
eBook Packages: Springer Book Archive